| Joe W Terry, MD | |
|
935 Highway 51, Madison, MS 39110-8407 | |
| (601) 856-5986 | |
| (601) 853-2321 |
| Full Name | Joe W Terry |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 37 Years |
| Location | 935 Highway 51, Madison, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376555334 | NPI | - | NPPES |
| 0122359 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11789 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home -flowood | Flowood, MS | Home health agency |
| Sta Home Health And Hospice | Clinton, MS | Home health agency |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Mississippi Methodist Rehab Ctr | Jackson, MS | Hospital |
| Merit Health Madison | Canton, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mea Primary Care Plus, Llc | 0941583728 | 42 |
| Quad Intermed Company Llc | 6709245954 | 48 |
News Archive
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.
Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.
The Entomological Society of America (ESA) recently released a statement supporting the creation and implementation of a national strategy using Integrated Tick Management to better control tick populations and reduce the rapidly escalating impact of tick-borne diseases such as Rocky Mountain spotted fever, tularemia, and Lyme disease.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
› Verified 2 days ago
| Entity Name | First Intermed Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669406658 PECOS PAC ID: 5294629895 Enrollment ID: O20040213000105 |
News Archive
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.
Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.
The Entomological Society of America (ESA) recently released a statement supporting the creation and implementation of a national strategy using Integrated Tick Management to better control tick populations and reduce the rapidly escalating impact of tick-borne diseases such as Rocky Mountain spotted fever, tularemia, and Lyme disease.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
› Verified 2 days ago
| Entity Name | Mea Primary Care Plus, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750826210 PECOS PAC ID: 0941583728 Enrollment ID: O20170202001116 |
News Archive
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.
Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.
The Entomological Society of America (ESA) recently released a statement supporting the creation and implementation of a national strategy using Integrated Tick Management to better control tick populations and reduce the rapidly escalating impact of tick-borne diseases such as Rocky Mountain spotted fever, tularemia, and Lyme disease.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
› Verified 2 days ago
| Entity Name | Quad Intermed Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952099913 PECOS PAC ID: 6709245954 Enrollment ID: O20230706000437 |
News Archive
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.
Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.
The Entomological Society of America (ESA) recently released a statement supporting the creation and implementation of a national strategy using Integrated Tick Management to better control tick populations and reduce the rapidly escalating impact of tick-borne diseases such as Rocky Mountain spotted fever, tularemia, and Lyme disease.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joe W Terry, MD 935 Highway 51, Madison, MS 39110-8407 Ph: (601) 856-5986 | Joe W Terry, MD 935 Highway 51, Madison, MS 39110-8407 Ph: (601) 856-5986 |
News Archive
Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.
In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.
Saint-Gobain Performance Plastics, the maker of Tygon® high-performance flexible tubing, has become the first manufacturer to introduce a bio-based, phthalate-free product for use in laboratory applications. DEHP Di(2-ethylhexyl phthalate), a common plasticizer, has been removed from existing Tygon® formulations.
The Entomological Society of America (ESA) recently released a statement supporting the creation and implementation of a national strategy using Integrated Tick Management to better control tick populations and reduce the rapidly escalating impact of tick-borne diseases such as Rocky Mountain spotted fever, tularemia, and Lyme disease.
Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product teduglutide (Revestive) as a once-daily treatment for adult patients with short bowel syndrome (SBS).
› Verified 2 days ago
Timothy Chin-yu Chen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 401 Baptist Dr, Suite 104, Madison, MS 39110 Phone: 601-605-2383 | |
Micah R. Walker, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 129 Fountains Blvd Ste 101, Madison, MS 39110 Phone: 769-300-0700 Fax: 769-300-0707 | |
Paul A Veregge, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 138 Fenwick Cir, Madison, MS 39110 Phone: 210-387-0306 | |
Brian Scott Torrey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 106 Highland Way, Suite 103, Madison, MS 39110 Phone: 601-200-4750 Fax: 601-200-4740 | |
Robert May, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 935 Highway 51, Madison, MS 39110 Phone: 601-856-5986 Fax: 601-853-2321 | |
Dr. Reginald D Rigsby, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1082 Gluckstadt Rd, Madison, MS 39110 Phone: 601-707-5621 Fax: 601-707-5627 |